FindTrial
Sign In

Clinical trial to study the effect of Rajikushthadi Lepa in pama with special reference to scabies

Randomised controlled clinical trial to study the effect of Rajikushthadi Lepa in Pama with special reference to scabies in school going children - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071839
Enrollment
74
Registered
2024-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Shruti Bhaskar Bhadane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of school going age group (6 -12 years) Patients fulfilling the clinical diagnostic criterion for scabies Selection of patient will be performed irrespective of sex, socio economic status and community Parents willing to give consent in written for the treatment

Exclusion criteria

Exclusion criteria: Patients of other age group Pama associated with immunodeficiency disorders such as HIV Scabies with crust or hyperkeratosis and secondary infection Known cases of systemic disorders such as diabetes mellitus type 1 Pama associated with any secondary infection.

Design outcomes

Primary

MeasureTime frame
Reduction in signs and symptoms of pama like Kandu(itching),Tod(pain),Dah (burning sensation),Pitika(Burrows),Strav(discharge) after application of Rajikushthadi lepaTimepoint: 11 days—

Secondary

MeasureTime frame
To compare the effect of trial & control drug on following signs & symptoms of pama Kandu(itching)Toda(Pain) Pitika(Burrows) Strav(Discharge) Dah(Burning sensation)Timepoint: 18 month—

Countries

India

Contacts

Public ContactDr Shruti Bhaskar Bhadane

SMBT ayurvrd college and hospital

suvisa65@gmail.com9420373110

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026